Scientists at the University of Southern California have engineered synthetic organiser cells that produce localised Wnt ...

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) today announced the initiation of PRESERVE, a Phase 4, multicenter study investigating the combination of LUPKYNIS® and belimumab, obinutuzumab or ...

Kidney disease quietly builds in the background, and by the time you actually feel something, the damage may already be significant. According to Mayo Clinic, symptoms of kidney disease are often ...

In a study published in Science, USC researchers paired a biological discovery with an engineering feat to create more faithful, reproducible lab-grown kidney structures from stem cells, known as ...

An exploratory analysis suggests finerenone may ease kidney function in patients with glomerular diseases. Finerenone slows kidney function decline, decreases albuminuria, and reduces the risk of ...

The drug finerenone significantly slows the decline in kidney function in patients with chronic kidney disease (CKD) who do not have diabetes. This is shown by an international study led by clinical ...

A phase 2 trial suggests that a drug commonly used for constipation may help preserve kidney function in people with moderate to severe chronic kidney disease by reshaping the gut microbiome and ...

A pioneering technology has been developed that enables human kidney organoids to be produced in a scalable manner by allowing the organoids to be combined with ex vivo pig kidneys and then ...

“You’re on a chemotherapeutic and your oncologist may say that your dosage is X, while a nephrologist is telling you that the proximal tubules in your kidneys can’t handle it. You’re harming them.” ...

Three years ago, the FDA found so many violations at a Nephron Pharmaceuticals manufacturing facility that the U.S. regulator admitted in a warning letter the issues were so numerous they couldn’t all ...